Therapeutic potential of biofilm-dispersing enzymes

International Journal of Artificial Organs

Volumn 32, Issue 9, 2009, Pages 545-554

  Kaplan, Jeffrey B ^a,b  

^a RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Biofilm; Device infection; Dispersin B; DNase I; Extracellular DNA; PNAG

Indexed keywords

ANTIMICROBIAL AGENTS; BACTERIA; BIODEGRADATION; BIOMEDICAL EQUIPMENT; ENZYMES; FUNCTIONAL POLYMERS;

ANTIBIOFILMS; BIOFILM MATRIX; COLONIES OF BACTERIA; DEVICE INFECTION; DISPERSIN B; DNASE I; EXTRACELLULAR; EXTRACELLULAR DNA; PNAG; THERAPEUTIC POTENTIALS;

BIOFILMS;

AMPICILLIN; BETA N ACETYLHEXOSAMINIDASE; CEFAMANDOLE NAFATE; CETYLPYRIDINIUM SALT; DEOXYRIBONUCLEASE I; DISPERSIN B; DODECYL SULFATE SODIUM; DORNASE ALFA; LEVOFLOXACIN; RIFAMPICIN; TEICOPLANIN; TRICLOSAN; UNCLASSIFIED DRUG;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERICIDAL ACTIVITY; BACTERIOPHAGE T7; BACTERIUM ADHERENCE; BIOFILM; BLOODSTREAM INFECTION; DEVICE INFECTION; ESCHERICHIA COLI; EXTRACELLULAR MATRIX; GROWTH INHIBITION; HOST RESISTANCE; HUMAN; INFECTION PREVENTION; MATERIAL COATING; NONHUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIAE;

EID: 70549098563     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880903200903     Document Type: Review

References (65)

1. Lentino JR. Prosthetic joint infections: bane of orthopedists, challenge for infectious disease specialists. Clin Infect Dis 2003; 36: 1157-61.
2. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-22.
3. Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis 2002; 8:881-90.
4. Sutherland IW. The biofilm matrix - an immobilized but dynamic microbial environment. Trends Microbiol 2001; 9: 222-7.
5. Branda SS, Vik A, Friedman L, Kolter R. Biofilms: the matrix revisited. Trends Microbiol 2005; 13: 20-6.
6. Mah T-F, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 2001; 9: 34-9.
7. Mulcahy H, Charron-Mazenod L, Lewenza S. Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLOS Pathog 2009; 4:e1000213. doi:10.1371/ journal.ppat.1000213
8. Xavier JB, Picioreanu C, Abdul Rani S, van Loosdrecht CM, Stewart PS. Biofilm-control strategies based on enzymic disruption of the extracellular polymeric substance matrix - a modelling study. Microbiology 2005; 151: 3817-32.
9. Izano EA, Shah SM, Kaplan JB. Intercellular adhesion and biocide resistance in nontypeable biofilms. Microb Pathogen 2009; 46: 207-13.
10. Leroy C, Delbarre C, Ghillebaert F, Compere C, Combes C. Effects of commercial enzymes on the adhesion of a marine biofilm-forming bacterium. Biofouling 2008; 24: 11-22.
11. Marion K, Pasmore M, Freney J, et al. A new procedure allowing the complete removal and prevention of hemodialysis biofilms. Blood Purif 2005; 23: 339-48.
12. Mecikoglu M, Saygi B, Yildirim Y, Karadag-Saygi E, Ramadan SS, Esemenli T. The effect of proteolytic enzyme serratiopeptidase in the treatment of experimental implant-related infection. J Bone Joint Surg 2006; 88: 1208-14.
13. Orgaz B, Kives J, Pedregosa AM, Monistrol IF, Laborda F, SanJosé C. Bacterial biofilm removal using fungal enzymes. Enzyme Microb Technol 2006; 40: 51-6.
14. Orgaz B, Neufeld RJ, SanJosé C. Single-step biofilm removal with delayed release encapsulated pronase mixed with soluble enzymes. Enzyme Microb Technol 2007; 40: 1045-51.
15. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS. Extracellular DNA required for bacterial biofilm formation. Science 2002; 295: 1487.
16. Andersson S, Dalhammar G, Land CJ, Kuttuva Rajarao G. Characterization of extracellular polymeric substances from denitrifying organism Comamonas denitrificans. Appl Microbiol Biotechnol 2009; 82: 535-43.
17. Eckhart L, Fisher H, Barken KB, Tolker-Nielsen T, Tschachler E. DNase1L2 suppresses biofilm formation by Pseudomonas aeruginosa and Staphylococcus aureus. Br J Dermatol 2007; 156: 1342-5.
18. Moscoso M, García E, López R. Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J Bacteriol 2006; 188: 7785-95.
19. Qin Z, Ou Y, Yang L, Zhu Y, Tolker-Nielsen T, Molin S, Qu D. Role of autolysin-mediated DNA release in biofilm formation of Staphylococcus epidermidis. Microbiology 2007; 153: 2083-92.
20. Rice KC, Mann EE, Endres JL, et al. The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc Natl Acad Sci USA 2007; 104: 8113-8.
21. Svensson SL, Davis LM, MacKichan JK, et al. The CprS sensor kinase of the zoonotic pathogen Campylobacter jejuni influences biofilm formation and is required for optimal chick colonization. Mol Microbiol 2009; 71: 253-72.
22. Seidl K, Goerke C, Wolz C, Mack D, Berger-Bächi B, Bischoff M. Staphylococcus aureus CcpA affects biofilm formation. Infect Immun 2008; 76: 2044-50.
23. Tetz GV, Artemenko NK, Tetz VV. Effect of DNase and antibiotics on biofilm characteristics. Antimicrob Agents Chemother 2009; 53: 1204-9.
24. Vilain S, Pretorius JM, Theron J, Brözel VS. DNA as an adhesin: Bacillus cereus requires extracellular DNA to form biofilm. Appl Environ Microbiol 2009; 75: 2861-8.
25. Medina AA, Kadouri DE. Biofilm formation of Bdellovibrio bacteriovorus host-independent derivatives. Res Microbiol 2009; 160: 224-31.
26. van Schaik EJ, Giltner CL, Audette GF, et al. DNA binding: a novel function of Pseudomonas aeruginosa type IV pili. J Bacteriol 2005; 187: 1455-64.
27. Allesen-Holm M, Barken KB, Yang L, et al. A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol Microbiol 2006; 59: 1114-28.
28. Hall-Stoodley L, Nistico L, Sambanthamoorthy K, et al. Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates. BMC Microbiol 2008; 8: 173.
29. Matsukawa M, Greenberg EP. Putative exopolysaccharide synthesis genes influence Pseudomonas aeruginosa biofilm development. J Bacteriol 2004; 186: 4449-56.
30. Böckelmann U, Lünsdorf H, Szewzyk U. Ultrastructural and electron energy-loss spectroscopic analysis of an extracellular filamentous matrix of an environmental bacterial isolate. Environ Microbiol 2007; 9: 2137-44.
31. Nemoto K, Hirota K, Murakami K, et al. Effect of Varidase (streptodornase) on biofilm formed by Pseudomonas aeruginosa. Chemotherapy 2003; 49: 121-5.
32. Izano EA, Amarante MA, Kher WB, Kaplan JB. Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Appl Environ Microbiol 2008; 74: 470-6.
33. Thomas VC, Thurlow LR, Boyle D, Hancock LE.Regulation of autolysis-dependent extracellular DNA release by Enterococcus faecalis extracellular proteases influences biofilm development. J Bacteriol 2008; 190: 5690-8.
34. Crecchio C, Ruggiero P, Curci M, Colombo C, Palumbo G, Stotzky G. Binding of DNA from Bacillus subtilis on montmorillonite - humic acids - aluminum or iron hydroxypolymers: effects on transformation and protection against DNase. Soil Sci Soc Am J 2005; 69: 834-41.
35. Romanowski G, Lorenz MG, Wackernagel W. Adsorption of plasmid DNA to mineral surfaces and protection against DNase I. Appl Environ Microbiol 1991; 57: 57-61.
36. Tavares F, Sellstedt A. DNase-resistant DNA in the extracellular and cell wall-associated fractions of Frankia strains R43 and CcI3. Curr Microbiol 2001; 42:168-72.
37. Agladze K, Wang X, Romeo T. Spatial periodicity of Escherichia coli K-12 biofilm microstructure initiates during a reversible, polar attachment phase of development and requires the polysaccharide adhesin PGA. J Bacteriol 2005; 187: 8237-46.
38. Kaplan JB, Velliyagounder K, Chandran R, et al. Genes involved in the synthesis and degradation of matrix polysaccharide in Actinobacillus actinomycetemcomitans and Actinobacillus pleuropneumoniae biofilms. J Bacteriol 2004; 186: 8213-20.
39. Mack D, Nedelmann M, Krokotsch A, Schwarzkopf A, Heesemann J, Laufs R. Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide adhesin. Infect Immun 1994; 62: 3244-53.
40. Kropec A, Maira-Litran T, Jefferson KK, et al. Poly-N-acetylglucosamine production in Staphylococcus aureus is essential for virulence in murine models of systemic infection. Infect Immun 2005; 73: 6868-76.
41. Vuong C, Voyich JM, Fischer ER, Braughton KR, Whitney AR, DeLeo FR, Otto M. Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system. Cell Microbiol 2004; 6: 269-75.
42. Vuong C, Kocianova S, Voyich JM, et al. A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion and virulence. J Biol Chem 2004; 279: 54881-6.
43. Parise Sloan G, Love CF, Sukumar N, Mishra M, Deora R. The Bordetella Bps polysaccharide is critical for biofilm development in the mouse respiratory tract. J Bacteriol 2007; 189: 8270-6.
44. Ramasubbu N, Thomas L, Ragunath, C, Kaplan JB. Structural analysis of dispersin B, a biofilm-releasing glycoside hydrolase from the periodontopathogen Actinobacillus actinomycetemcomitans. J Mol Biol 2005; 349: 475-86.
45. Kaplan JB, Chandran R, Ramasubbu N, Fine DH. Detachment of Actinobacillus actinomycetemcomitans biofilm cells by an endogenous β-hexosaminidase activity. J Bacteriol 2003; 185: 4693-8.
46. Izano EA, Sadovskaya I, Wang H, et al. Poly-N-acetylglucosamine mediates biofilm formation and detergent resistance in Aggregatibacter actinomycetemcomitans. Microb Pathogen 2008; 44: 52-60.
47. Itoh Y, Wang X, Hinnebusch BJ, Preston JF III, Romeo T. Depolymerization of β-1,6-N-acetyl-D-glucosamine disrupts the integrity of diverse bacterial biofilms. J Bacteriol 2005; 187: 382-7.
48. Izano EA, Sadovskaya I, Vinogradov E, et al. Poly-N-acetylglucosamine mediates biofilm formation and antibiotic resistance in Actinobacillus pleuropneumoniae. Microb Pathogen 2007; 43: 1-9.
49. Kaplan JB, Chandran R, Velliyagounder K., Fine DH, Ramasubbu N. Enzymatic detachment of Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother 2004; 48: 2633-6.
50. Irie Y, Preston A, Yuk MH. Expression of the primary carbohydrate component of the Bordetella bronchiseptica biofilm matrix is dependent on growth phase but independent of Bvg regulation. J Bacteriol 2006; 188: 6680-7.
51. Parise G, Mishra M, Itoh Y, Romeo T, Deora R. Role of a putative polysaccharide locus in Bordetella biofilm development. J Bacteriol 2007; 189: 750-60.
52. Donelli G, Francolini I, Romoli D, et al. Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother 2007; 51: 2733-40.
53. Lee J-H, Kaplan JB, Lee WY. Microfluidic devices for studying growth and removal of Staphylococcus epidermidis biofilms. Biomed Microdevices 2008; 10: 489-98.
54. Izano EA, Wang H, Ragunath C, Ramasubbu N, Kaplan JB. Detachment and killing of Aggregatibacter actinomycetemcomitans biofilms by dispersin B and SDS. J Dent Res 2007; 86: 618-22.
55. Lu TK, Collins JJ. Dispersing biofilms with engineered enzymatic bacteriophage. Proc Natl Acad Sci USA 2007; 104: 11197-202.
56. Venketaraman V, Lin AK, Le A, Kachlany SC, Connell ND, Kaplan JB. Both leukotoxin and poly-N-acetylglucosamine surface polysaccharide protect Aggregatibacter actinomycetemcomitans biofilm cells from macrophage killing. Microb Pathogen 2008; 45: 173-80.
57. Serrera A, del Pozo JL, Martinez A, et al. Dispersin B therapy of Staphylococcus aureus experimental port-related blood-stream infection. Abstract number: 1733-1282, 17th European Congress of Clinical Microbiology and Infectious Disease, Munich, Germany, 31 Mar - 04 Apr 2007. http://www.blackwellpublishing.com/eccmid17/ abstract.asp?id=57581
58. Darouiche RO, Mansouri MD, Gawande PV, Madhyastha S. Antimicrobial and antibiofilm efficacy of triclosan and DispersinB® combination. J Antimicrob Chemother 2009; 64: 89-93.
59. Shak S, Capon DJ, Hellmiss R, Marsters SA, Baker CL. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci USA 1990; 87: 9188-92.
60. Parks QM, Young RL, Poch KR, Malcolm KC, Vasil ML, Nick JA. Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy. J Med Microbiol 2009; 58: 492-502.
61. Rohde H, Burandt EC, Siemssen N, et al. Polysaccharide intercellular adhesin and protein factors in biofilm accumulation of Staphylococcus epidermidis and Staphylococcus aureus isolated from prosthetic hip and knee joint infections. Biomaterials 2007; 28: 1711-20.
62. Inoue T, Shingaki R, Sogawa N, Sogawa CA, Asaumi J, Kokeguchi S, Fukui K. Biofilm formation by a fimbriae-deficient mutant of Actinobacillus actinomycetemcomitans. Microbiol Immunol 2003; 47: 877-81.
63. Fredheim EG, Klingenberg C, Rohde H, et al. Biofilm formation by Staphylococcus haemolyticus. J Clin Microbiol 2009; 47: 1172-80.
64. Petersen FC, Pecharki D, Scheie AA. Biofilm mode of growth of Streptococcus intermedius favored by a competence-stimulating signaling peptide. J Bacteriol 2004; 186: 6327-6331.
65. Petersen FC, Tao L, Scheie AA. DNA binding-uptake system: a link between cell-to-cell communication and biofilm formation. J Bacteriol 2005; 187: 4392-400.